Urovant Sciences Ltd.
DelistedCIK 1740547fmd_0N47VW95Q575S0HJ2SGASZ5W0VManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2017 to Dec 31, 2020, 15 periods
| Line item | FY2018 | FY2019 | FY2020 |
|---|---|---|---|
| Net interest income | – | (0) | (4) |
| Research and development | 32 | 92 | 92 |
| Total operating expenses | 37 | 111 | 139 |
| Other non-operating income (expense) | – | (0) | (0) |
| Income before taxes | (37) | (111) | (147) |
| Income tax expense | 0 | 0 | 0 |
| Net income from continuing operations | (37) | (111) | (147) |
| Net income | (37) | (111) | (147) |